SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 NGS Genetic DNA Test
Comprehensive Genetic Analysis for Metabolic Disorders
The SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 NGS Genetic DNA Test represents a breakthrough in genetic diagnostics for metabolic disorders. This advanced screening utilizes cutting-edge Next-Generation Sequencing (NGS) technology to identify mutations in the SLC16A1 gene, which plays a critical role in glucose metabolism and insulin regulation. Hyperinsulinemic hypoglycemia type 7 is a rare but serious condition characterized by excessive insulin production leading to dangerously low blood sugar levels, potentially causing neurological damage if left undiagnosed.
What This Test Detects
Our comprehensive genetic analysis specifically targets:
- Mutations in the SLC16A1 gene encoding monocarboxylate transporter 1 (MCT1)
- Genetic variants affecting pyruvate transport and lactate metabolism
- Inherited patterns of hyperinsulinemic hypoglycemia
- Specific nucleotide changes associated with metabolic dysregulation
- Carrier status for autosomal recessive inheritance patterns
Who Should Consider This Test
This genetic screening is recommended for individuals experiencing:
- Unexplained recurrent hypoglycemia episodes
- Neurological symptoms during fasting or exercise
- Family history of metabolic disorders or unexplained infant deaths
- Developmental delays associated with glucose metabolism issues
- Exercise-induced hypoglycemia or metabolic crises
- Diagnostic uncertainty in cases of persistent low blood sugar
Key Benefits of Genetic Testing
- Accurate Diagnosis: Provides definitive identification of genetic causes
- Personalized Treatment: Enables targeted therapeutic interventions
- Family Planning: Informs reproductive decisions and genetic counseling
- Early Intervention: Facilitates proactive management strategies
- Comprehensive Analysis: Utilizes advanced NGS technology for thorough screening
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert genetic counselors:
- Positive Result: Indicates presence of SLC16A1 gene mutation, confirming diagnosis
- Negative Result: Suggests absence of tested mutations, though other causes should be considered
- Variant of Uncertain Significance: Requires additional family studies and clinical correlation
- Carrier Status: Important for family planning and genetic counseling
Test Pricing Information
| Price Type | Amount (USD) |
|---|---|
| Discount Price | $500 |
| Regular Price | $700 |
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities. Our network of certified genetic testing facilities ensures accessibility and convenience for patients nationwide.
Take Control of Your Health Today
Don’t let unexplained symptoms compromise your quality of life. Our SLC16A1 Gene Hyperinsulinemic Hypoglycemia Type 7 NGS Genetic DNA Test provides the clarity needed for proper diagnosis and management. With results available in 3-4 weeks and comprehensive genetic counseling included, you’ll receive the expert guidance necessary for informed healthcare decisions.
Call us now at +1(267) 388-9828 to schedule your genetic test or book online through our secure patient portal. Our genetic specialists are ready to assist you with personalized care and comprehensive support throughout your testing journey.
